Product Code: ETC13149377 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Neuroendovascular Coil Market was valued at USD 0.95 Billion in 2024 and is expected to reach USD 1.3 Billion by 2031, growing at a compound annual growth rate of 5.10% during the forecast period (2025-2031).
The Global Neuroendovascular Coil Market is experiencing steady growth driven by increasing prevalence of neurological disorders such as aneurysms and strokes. Neuroendovascular coils are utilized in minimally invasive procedures to treat these conditions, offering benefits such as reduced recovery times and lower risks compared to traditional surgical methods. Technological advancements, such as the development of detachable and bioactive coils, are further propelling market growth. Key market players are focusing on product innovation, strategic collaborations, and geographical expansions to gain a competitive edge in this rapidly evolving market. North America currently dominates the market due to high healthcare expenditure and advanced healthcare infrastructure, while Asia Pacific is anticipated to witness significant growth opportunities attributed to rising healthcare investments and increasing awareness about neuroendovascular treatments.
The Global Neuroendovascular Coil Market is witnessing a shift towards the development of advanced coil technologies, such as detachable coils and bioactive coils, to improve treatment outcomes for aneurysms and other neurovascular conditions. The market is also experiencing a growing demand for minimally invasive procedures, driving the adoption of neuroendovascular coils as a preferred treatment option. Additionally, the increasing prevalence of neurological disorders and cerebrovascular diseases is creating opportunities for market growth. Emerging markets in Asia-Pacific and Latin America present untapped potential for market expansion due to improving healthcare infrastructure and rising awareness about neuroendovascular treatments. Collaboration between medical device companies and research institutions for product innovation and clinical studies is expected to further drive the market`s growth and competitiveness.
The Global Neuroendovascular Coil Market faces several challenges, including stringent regulations and approval processes for new products, high costs associated with research and development, and limited reimbursement coverage for neuroendovascular procedures in certain regions. Additionally, increased competition among manufacturers and the need for continuous technological advancements to improve the efficacy and safety of neuroendovascular coils pose challenges for market growth. Moreover, the complexity of neuroendovascular procedures and the specialized training required for healthcare professionals to perform these interventions can also be seen as obstacles in expanding the market. Overall, overcoming these challenges will require innovative strategies, collaborative efforts between industry stakeholders, and a focus on enhancing patient outcomes to drive the growth of the Global Neuroendovascular Coil Market.
The Global Neuroendovascular Coil Market is primarily driven by the increasing prevalence of neurological disorders such as strokes and aneurysms, leading to a growing demand for minimally invasive treatment options. Technological advancements in neuroendovascular coils, such as the development of detachable coils and bioactive coils for improved patient outcomes, are also propelling market growth. Additionally, rising healthcare expenditure, growing awareness about the benefits of neuroendovascular procedures, and expanding healthcare infrastructure in emerging economies are further contributing to market expansion. The shift towards endovascular coiling as a preferred treatment option over traditional surgical methods, due to its lower risk of complications and faster recovery times, is expected to sustain market growth in the coming years.
Government policies related to the Global Neuroendovascular Coil Market primarily focus on regulating the manufacturing, marketing, and usage of neuroendovascular coils to ensure patient safety and product efficacy. Regulatory bodies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe set stringent guidelines for the approval and monitoring of neuroendovascular coils. These policies aim to assess the quality, performance, and safety of these medical devices through pre-market approvals, post-market surveillance, and periodic inspections. Additionally, reimbursement policies by government healthcare systems influence market dynamics by determining the financial support available for neuroendovascular coil procedures, impacting adoption rates and market growth. Compliance with these regulations is crucial for manufacturers to enter and sustain in the Global Neuroendovascular Coil Market.
The Global Neuroendovascular Coil Market is expected to witness significant growth in the coming years, driven by increasing prevalence of neurological disorders such as aneurysms and strokes, coupled with advancements in minimally invasive neurosurgical procedures. The rising geriatric population, along with the growing adoption of innovative technologies in healthcare, will further boost market expansion. Additionally, the increasing awareness about early diagnosis and treatment of neurovascular diseases, as well as the expanding healthcare infrastructure in emerging economies, will contribute to market growth. Key players in the industry are focusing on developing novel neuroendovascular coil technologies to enhance patient outcomes and improve treatment efficacy. Overall, the Global Neuroendovascular Coil Market is poised for steady growth in the foreseeable future.
In the Global Neuroendovascular Coil Market, North America holds a significant share due to the high prevalence of neurovascular disorders, advanced healthcare infrastructure, and increasing adoption of minimally invasive procedures. Europe follows closely behind, driven by the presence of key market players, rising geriatric population, and growing investments in healthcare. The Asia-Pacific region is poised for substantial growth with improving healthcare facilities, increasing awareness about neurological diseases, and rising disposable incomes. The Middle East and Africa region is witnessing a gradual uptake of neuroendovascular coils, supported by expanding healthcare access and infrastructure development. Latin America is also showing potential for market growth, fueled by improving healthcare standards, rising healthcare expenditure, and a growing focus on enhancing treatment options for neurological disorders.
Global Neuroendovascular Coil Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Neuroendovascular Coil Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Neuroendovascular Coil Market Revenues & Volume, 2021 & 2031F |
3.3 Global Neuroendovascular Coil Market - Industry Life Cycle |
3.4 Global Neuroendovascular Coil Market - Porter's Five Forces |
3.5 Global Neuroendovascular Coil Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Neuroendovascular Coil Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Neuroendovascular Coil Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Global Neuroendovascular Coil Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Neuroendovascular Coil Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Neuroendovascular Coil Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Neuroendovascular Coil Market Trends |
6 Global Neuroendovascular Coil Market, 2021 - 2031 |
6.1 Global Neuroendovascular Coil Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Neuroendovascular Coil Market, Revenues & Volume, By Guglielmi Detachable Coils (GDCs), 2021 - 2031 |
6.1.3 Global Neuroendovascular Coil Market, Revenues & Volume, By Matrix Coils, 2021 - 2031 |
6.2 Global Neuroendovascular Coil Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Neuroendovascular Coil Market, Revenues & Volume, By Ruptured Aneurysm, 2021 - 2031 |
6.2.3 Global Neuroendovascular Coil Market, Revenues & Volume, By Unruptured Aneurysm, 2021 - 2031 |
6.3 Global Neuroendovascular Coil Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Neuroendovascular Coil Market, Revenues & Volume, By Tumor Surgery, 2021 - 2031 |
6.3.3 Global Neuroendovascular Coil Market, Revenues & Volume, By Medical Teaching, 2021 - 2031 |
6.3.4 Global Neuroendovascular Coil Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Neuroendovascular Coil Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Neuroendovascular Coil Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Neuroendovascular Coil Market, Revenues & Volume, By Ambulatory Surgical Centers (ASCs), 2021 - 2031 |
6.4.4 Global Neuroendovascular Coil Market, Revenues & Volume, By Stroke Centers, 2021 - 2031 |
6.4.5 Global Neuroendovascular Coil Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Neuroendovascular Coil Market, Overview & Analysis |
7.1 North America Neuroendovascular Coil Market Revenues & Volume, 2021 - 2031 |
7.2 North America Neuroendovascular Coil Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Neuroendovascular Coil Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Neuroendovascular Coil Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5 North America Neuroendovascular Coil Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Neuroendovascular Coil Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Neuroendovascular Coil Market, Overview & Analysis |
8.1 Latin America (LATAM) Neuroendovascular Coil Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Neuroendovascular Coil Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Neuroendovascular Coil Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Neuroendovascular Coil Market, Revenues & Volume, By Indication, 2021 - 2031 |
8.5 Latin America (LATAM) Neuroendovascular Coil Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Neuroendovascular Coil Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Neuroendovascular Coil Market, Overview & Analysis |
9.1 Asia Neuroendovascular Coil Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Neuroendovascular Coil Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Neuroendovascular Coil Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Neuroendovascular Coil Market, Revenues & Volume, By Indication, 2021 - 2031 |
9.5 Asia Neuroendovascular Coil Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Neuroendovascular Coil Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Neuroendovascular Coil Market, Overview & Analysis |
10.1 Africa Neuroendovascular Coil Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Neuroendovascular Coil Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Neuroendovascular Coil Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Neuroendovascular Coil Market, Revenues & Volume, By Indication, 2021 - 2031 |
10.5 Africa Neuroendovascular Coil Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Neuroendovascular Coil Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Neuroendovascular Coil Market, Overview & Analysis |
11.1 Europe Neuroendovascular Coil Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Neuroendovascular Coil Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Neuroendovascular Coil Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Neuroendovascular Coil Market, Revenues & Volume, By Indication, 2021 - 2031 |
11.5 Europe Neuroendovascular Coil Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Neuroendovascular Coil Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Neuroendovascular Coil Market, Overview & Analysis |
12.1 Middle East Neuroendovascular Coil Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Neuroendovascular Coil Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Neuroendovascular Coil Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Neuroendovascular Coil Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Neuroendovascular Coil Market, Revenues & Volume, By Indication, 2021 - 2031 |
12.5 Middle East Neuroendovascular Coil Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Neuroendovascular Coil Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Neuroendovascular Coil Market Key Performance Indicators |
14 Global Neuroendovascular Coil Market - Export/Import By Countries Assessment |
15 Global Neuroendovascular Coil Market - Opportunity Assessment |
15.1 Global Neuroendovascular Coil Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Neuroendovascular Coil Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Neuroendovascular Coil Market Opportunity Assessment, By Indication, 2021 & 2031F |
15.4 Global Neuroendovascular Coil Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Neuroendovascular Coil Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Neuroendovascular Coil Market - Competitive Landscape |
16.1 Global Neuroendovascular Coil Market Revenue Share, By Companies, 2024 |
16.2 Global Neuroendovascular Coil Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |